Key result
ECPELLA successfully bridges severe immune checkpoint inhibitor myocarditis to recovery.
Answers are grounded in this paper and cite their sources.
Investigates myocarditis treatment outcomes in a 60-year-old female with colon cancer, suggesting effective management strategies.
As immunotherapy use in various malignancies expands, immune checkpoint inhibitor (ICI) myocarditis is a rare but potentially fatal complication requiring a high degree of clinical suspicion for early diagnosis and treatment. A 60 year-old female with colon cancer status post 3 months of nivolumab
No takes yet. Share an insight, caveat, or question.
Stein-Merlob et al. (2020) studied this question. Simultaneous venoarterial ECMO and Impella support successfully served as a bridge to recovery for a patient with severe immune checkpoint inhibitor myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: